Wu Q, Wang H, He F, et al. Depletion of microRNA-92a enhances the role of sevoflurane treatment in reducing myocardial ischemia–reperfusion injury by upregulating KLF4. Cardiovasc Drugs Ther. 2022. https://doi.org/10.1007/s10557-021-07303-x.

Hinkel R, Penzkofer D, Zühlke S, et al. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation. 2013;128(10):1066–75.

Article  CAS  PubMed  Google Scholar 

Zhang B, Zhou M, Li C, et al. MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7. PLoS One. 2014;9(6):e100298.

Article  PubMed  PubMed Central  Google Scholar 

Jiang F, Zhang B, Zhang X, et al. miRNA-92a inhibits vascular smooth muscle cell phenotypic modulation and may help prevent in-stent restenosis. Mol Med Rep. 2023;27(2):40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma M, Li H, Yin S, Lin T, Song T. Overexpression of miR-92a attenuates kidney ischemia-reperfusion injury and improves kidney preservation by inhibiting MEK4/JNK1-related autophagy. Cell Mol Biol Lett. 2023;28(1):20.

Article  CAS  PubMed  PubMed Central  Google Scholar